Thyroid Cancer Clinical Trials

Find Thyroid Cancer Clinical Trials Near You

Urinary Exosomal Biomarkers of Thyroglobulin and Galectin-3 for Prognosis and Follow-up in Patients of Well-differentiated Thyroid Cancer

Status: Active_not_recruiting
Location: See location...
Study Type: Observational
SUMMARY

Now, the investigators carried out a prospective study enrolling patients with thyroid cancer, who had received ablative thyroidectomy and /or radioactive iodine therapy for two more years. The investigators' study already enrolled seventy-three patients with thyroid cancer, and the investigators plan to enroll 30 new patients in this consecutive research study. All patients received total thyroidectomy under clinically surgical judgement in initial therapeutic option. The investigators also further found some difference between papillary thyroid cancer and follicular thyroid cancer, and the investigators will continue annually to closely monitor the change of U-Ex Tg and urinary exosomal galectin-3 between differently cellular types of thyroid cancers.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 20
Maximum Age: 80
Healthy Volunteers: f
View:

• diagnosed patients with thyroid papillary, follicular and anaplastic thyroid cancer, post-operation follow up

Locations
Other Locations
Taiwan
Chih-Yuan Wang, M.D
Taipei
Time Frame
Start Date: 2021-08-19
Completion Date: 2026-10-31
Participants
Target number of participants: 103
Sponsors
Leads: National Taiwan University Hospital

This content was sourced from clinicaltrials.gov